sodium glutamate has been researched along with Non-alcoholic Fatty Liver Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo-Santos, APS; Coelho, CFF; Dos Santos, AM; França, LM; Nascimento, FRF; Nascimento, JR; Paes, AMA | 1 |
| Aburada, M; Fujimoto, M; Gershwin, ME; Iizuka, S; Nagata, M; Nakanishi, Y; Nomoto, K; Salunga, TL; Sasaki, Y; Selmi, C; Shimada, T; Shimada, Y; Suzuki, W; Tsuneyama, K | 1 |
| Han, MM; Li, DS; Ma, L; Ren, GP; Ye, XL; Yu, D; Zhang, TY; Zhang, ZY; Zhao, JZ; Zhu, SL | 1 |
| Baba, H; Fujimoto, M; Hayashi, S; Hokao, R; Imura, J; Miwa, S; Nakajima, T; Nishida, T; Nomoto, K; Oda, E; Sutoh, M; Taira, S; Tsuneyama, K | 1 |
| Beregova, T; Falalyeyeva, T; Kobyliak, N; Kondro, M; Savcheniuk, O; Virchenko, O | 1 |
| Beregova, T; Bodnar, P; Falalyeyeva, T; Kobyliak, N; Mykhalchyshyn, G; Ostapchenko, L; Spivak, M; Virchenko, O; Yankovsky, D | 1 |
| Beregova, T; Bodnar, P; Falalyeyeva, T; Kobyliak, N | 1 |
| Belemets, N; Beregova, T; Bodnar, P; Caprnda, M; Delev, D; Falalyeyeva, T; Galenova, T; Kobyliak, N; Kruzliak, P; Olena, T; Opatrilova, R; Ostapchenko, L; Rodrigo, L; Savchuk, O; Skladany, L; Virchenko, O | 1 |
| Aburada, M; Hokao, R; Iizuka, S; Makihara, H; Sasaki, Y; Shimada, T; Suzuki, W; Teraoka, R; Tsuneyama, K | 1 |
| Constantin, RP; da Costa, CE; de Oliveira, MC; Garcia, RF; Ishii-Iwamoto, EL; Lazarin, Mde O; Salgueiro-Pagadigorria, CL; Vitoriano, Ade S; Yamamoto, NS | 1 |
10 other study(ies) available for sodium glutamate and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
Topics: Abdominal Fat; Adolescent; Adult; Age Factors; Age of Onset; Animals; Animals, Newborn; Disease Models, Animal; Disease Progression; Female; Humans; Hypertriglyceridemia; Lipid Metabolism; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Sodium Glutamate; Young Adult | 2019 |
A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis.
Topics: Animals; Diet, Reducing; Disease Progression; Fatty Liver; Humans; Male; Mice, Inbred ICR; Non-alcoholic Fatty Liver Disease; Obesity; Sodium Glutamate | 2014 |
[Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism].
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Dyslipidemias; Energy Metabolism; Fatty Liver; Female; Fibroblast Growth Factors; Insulin Resistance; Lipolysis; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Sodium Glutamate | 2013 |
Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
Topics: Animals; Blood Glucose; Body Mass Index; Cholesterol; Diabetes Mellitus; Flavoring Agents; Humans; Liver; Male; Metabolic Syndrome; Mice, Inbred Strains; Non-alcoholic Fatty Liver Disease; Obesity; Sodium Glutamate; Triglycerides | 2014 |
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.
Topics: Adiponectin; Adiposity; Animals; Animals, Newborn; Body Weight; Drug Administration Schedule; Fatty Liver; Female; Insulin Resistance; Leptin; Male; Non-alcoholic Fatty Liver Disease; Obesity; Probiotics; Rats; Rats, Wistar; Sodium Glutamate | 2014 |
Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Topics: Acetobacter; Animals; Bifidobacterium; Disease Models, Animal; Flavoring Agents; Freeze Drying; Lacticaseibacillus casei; Lactococcus; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Probiotics; Propionibacterium; Rats; Rats, Wistar; Sodium Glutamate; Triglycerides | 2016 |
Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Fatty Acids; Fatty Acids, Omega-3; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Probiotics; Rats; Rats, Wistar; Sodium Glutamate; Triglycerides | 2017 |
Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
Topics: Adipokines; Adipose Tissue; Animals; Animals, Newborn; Antioxidants; Cytokines; Liver; Male; Melanins; Non-alcoholic Fatty Liver Disease; Obesity, Abdominal; Polyphenols; Rats; Rats, Wistar; Reactive Oxygen Species; Sodium Glutamate | 2017 |
Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
Topics: Adipose Tissue; Animals; Bezafibrate; Diabetes Mellitus; Disease Models, Animal; Eating; Fatty Liver; Gene Expression Regulation; Glucose Tolerance Test; Glycosuria; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; RNA, Messenger; Sodium Glutamate | 2011 |
Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium L-glutamate in rats.
Topics: Animals; Animals, Newborn; Fatty Liver; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Male; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Oxidative Phosphorylation; Rats; Rats, Wistar; Sodium Glutamate | 2011 |